HAVN Life Announces Departure Of Rick Brar As Director

HAVN Life Announces Departure Of Rick Brar As Director

Vancouver, BC – HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP)  (the “Company” or “HAVN Life”) announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company (“Board”) and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar’s services to the Company and wishes him well in his future endeavours.

On behalf of the Board, Mr. Vic Neufeld, Chairman of the Board, stated, “Mr. Brar has been instrumental in helping HAVN Life navigate the psychedelic sector as a start-up company in a nascent industry. We recognize the time commitments he has with his involvement in other businesses and truly appreciate his efforts and participation in our journey.”

On Behalf of The Board of Directors
Tim Moore
Chief Executive Officer and Director

About HAVN Life Sciences Inc.

HAVN Life Sciences is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind.

Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, HAVN Life offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.

Purchase our products and find out more at yourhavnlife.com, and follow us on FacebookTwitter,  Instagram and Youtube.